Market Tracker

08/29 6:01pm ET

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

289.72
Data as of Aug 29
 +0.62 / +0.21%
Today’s Change
45.40
Today|||52-Week Range
497.00
+324.31%
Year-to-Date

Today’s Trading

Previous close289.10
Today’s open290.05
Day’s range286.10 - 292.49
Volume322,789
Average volume (3 months)526,949
Market cap$6.1B
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)+48.91%
Earnings growth (this year)-253.67%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-33.71%
P/E ratioNM
Price/Sales759.12
Price/Book68.17

Competitors

 Today’s
change
Today’s
% change
IDXXIDEXX Laboratories I...+0.26+0.21%
ALKSAlkermes Plc+0.25+0.56%
UTHRUnited Therapeutics ...+26.14+28.51%
SGENSeattle Genetics Inc+0.44+1.01%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$1.07
Annual revenue (last year)$1.6M
Annual profit (last year)-$67.8M
Net profit margin-4,180.52%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts